Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells

BACKGROUND: There are many types of therapies for cancer. In these days, immunotherapies, especially immune checkpoint inhibitors, are focused on. Though many types of immune checkpoint inhibitors are there, the difference of effect and its mechanism are unclear. Some reports suggest the response ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Kazushige, Okamoto, Masanori, Sasaki, Jun, Kuroda, Chika, Ishida, Haruka, Ueda, Katsuya, Ideta, Hirokazu, Kamanaka, Takayuki, Sobajima, Atsushi, Takizawa, Takashi, Tanaka, Manabu, Aoki, Kaoru, Uemura, Takeshi, Kato, Hiroyuki, Haniu, Hisao, Saito, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950856/
https://www.ncbi.nlm.nih.gov/pubmed/31914969
http://dx.doi.org/10.1186/s12885-019-6499-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950856/
https://www.ncbi.nlm.nih.gov/pubmed/31914969
http://dx.doi.org/10.1186/s12885-019-6499-y

Ejemplares similares